enVVeno Medical Corporati... (NVNO)
2.75
-0.08 (-2.83%)
At close: Mar 28, 2025, 3:59 PM
2.80
1.86%
After-hours: Mar 28, 2025, 05:25 PM EDT
-2.83% (1D)
| Bid | 2.71 |
| Market Cap | 48.14M |
| Revenue (ttm) | 830.66K |
| Net Income (ttm) | -22.32M |
| EPS (ttm) | -1.27 |
| PE Ratio (ttm) | -2.16 |
| Forward PE | -2.67 |
| Analyst | n/a |
| Ask | 3.2 |
| Volume | 66,840 |
| Avg. Volume (20D) | 102,076 |
| Open | 2.85 |
| Previous Close | 2.83 |
| Day's Range | 2.70 - 2.85 |
| 52-Week Range | 2.45 - 6.48 |
| Beta | 1.38 |
About NVNO
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blo...
Industry Medical - Devices
Sector Healthcare
IPO Date May 31, 2018
Employees 37
Stock Exchange NASDAQ
Ticker Symbol NVNO
Website https://www.envveno.com
6 months ago
-28%
EnVVeno Medical shares are trading lower after the...
Unlock content with
Pro Subscription
6 months ago
-1.75%
EnVVeno Medical shares are trading lower after the company announced a proposed public offering.
1 month ago · accessnewswire.com
enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceOn-demand video webcast now available here IRVINE, CA / ACCESS Newswire / February 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of...
